212 related articles for article (PubMed ID: 26025060)
21. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Li M; Li Y; Liu X; Gao X; Wang Y
J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
[TBL] [Abstract][Full Text] [Related]
22. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
23. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
[TBL] [Abstract][Full Text] [Related]
24. Active Induction of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice.
Contarini G; Giusti P; Skaper SD
Methods Mol Biol; 2018; 1727():353-360. PubMed ID: 29222794
[TBL] [Abstract][Full Text] [Related]
25. Role of orexin-A in experimental autoimmune encephalomyelitis.
Fatemi I; Shamsizadeh A; Ayoobi F; Taghipour Z; Sanati MH; Roohbakhsh A; Motevalian M
J Neuroimmunol; 2016 Feb; 291():101-9. PubMed ID: 26857503
[TBL] [Abstract][Full Text] [Related]
26. Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.
Mimura LA; Chiuso-Minicucci F; Fraga-Silva TF; Zorzella-Pezavento SF; França TG; Ishikawa LL; Penitenti M; Ikoma MR; Sartori A
Neuroscience; 2016 Mar; 317():130-40. PubMed ID: 26762804
[TBL] [Abstract][Full Text] [Related]
27. Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Yin JX; Tang Z; Gan Y; Li L; Shi F; Coons S; Shi J
Neuropharmacology; 2014 Jun; 81():1-5. PubMed ID: 24486709
[TBL] [Abstract][Full Text] [Related]
28. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
Peng W
Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
[TBL] [Abstract][Full Text] [Related]
29. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Xu J; Wagoner G; Douglas JC; Drew PD
J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
[TBL] [Abstract][Full Text] [Related]
30. Single β³-amino acid substitutions to MOG peptides suppress the development of experimental autoimmune encephalomyelitis.
McDonald CA; Payne NL; Sun G; Clayton DJ; Del Borgo MP; Aguilar MI; Perlmutter P; Bernard CC
J Neuroimmunol; 2014 Dec; 277(1-2):67-76. PubMed ID: 25454728
[TBL] [Abstract][Full Text] [Related]
31. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis.
Garay L; Gonzalez Deniselle MC; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
J Neuroimmunol; 2014 Nov; 276(1-2):89-97. PubMed ID: 25200475
[TBL] [Abstract][Full Text] [Related]
33. Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
Aghaie T; Jazayeri MH; Avan A; Anissian A; Salari AA
IUBMB Life; 2019 Sep; 71(9):1313-1321. PubMed ID: 30957389
[TBL] [Abstract][Full Text] [Related]
34. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
[TBL] [Abstract][Full Text] [Related]
36. Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Seo JE; Hasan M; Han JS; Kang MJ; Jung BH; Kwok SK; Kim HY; Kwon OS
J Neuroimmunol; 2015 Oct; 287():43-53. PubMed ID: 26439961
[TBL] [Abstract][Full Text] [Related]
37. Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist.
Lou ZY; Zhao CB; Xiao BG
J Neurosci Res; 2012 Jan; 90(1):84-95. PubMed ID: 21922514
[TBL] [Abstract][Full Text] [Related]
38. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis.
Prochnow N; Gold R; Haghikia A
J Neuroimmunol; 2013 Nov; 264(1-2):48-53. PubMed ID: 24090654
[TBL] [Abstract][Full Text] [Related]
39. Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
Stephenson EL; Mishra MK; Moussienko D; Laflamme N; Rivest S; Ling CC; Yong VW
Brain; 2018 Apr; 141(4):1094-1110. PubMed ID: 29506186
[TBL] [Abstract][Full Text] [Related]
40. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]